share_log

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

Harvard Bioscience, Inc. to Participate in March 2024 Investor Conferences: Sidoti's Small Cap Conference and KeyBanc's Life Sciences & MedTech Conference

哈佛生物科學公司將參加2024年3月的投資者會議：西多蒂的小盤股會議和KeyBanc的生命科學與醫療技術會議
GlobeNewswire ·  03/11 20:00

HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024. Joining him will be Jennifer Cote, the Company's Chief Financial Officer.

馬薩諸塞州霍利斯頓，2024年3月11日（GLOBE NEWSWIRE）——哈佛生物科學公司（納斯達克股票代碼：HBIO）今天宣佈，董事長兼首席執行官吉姆·格林將在即將於2024年3月舉行的西多蒂小型股會議和KeyBanc生命科學與醫療技術會議上向投資者發表演講。公司首席財務官詹妮弗·科特將加入他的行列。

Both presentations will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website: Replays will be available on the Company's website shortly after each presentation has concluded.

兩場演講都將通過網絡直播，並可通過哈佛生物科學網站的投資者關係部分進行訪問：每場演講結束後不久，公司網站上將提供重播。

Conference Details:

會議詳情：

  • Sidoti Small Cap Conference
    • Presentation: Thursday, March 14th at 10:45 am ET
  • 西多蒂小盤股會議
    • 演講：3月14日星期四第四 美國東部時間上午 10:45
  • KeyBanc Life Sciences & Medtech Conference
    • Fireside Chat: Tuesday, March 19th at 9:45 am ET
  • KeyBanc 生命科學與醫療技術會議
    • 爐邊談話：3 月 19 日星期二第四 美國東部時間上午 9:45

The Company's management will engage in virtual one-on-one meetings with institutional investors in conjunction with both conferences. To schedule a one-on-one meeting, please contact the conference organizers directly.

公司管理層將在兩次會議的同時與機構投資者進行虛擬的一對一會議。要安排一對一的會議，請直接聯繫會議組織者。

About Harvard Bioscience, Inc.

哈佛生物科學公司簡介

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world's leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at

Harvard Bioscience, Inc. 是一家領先的技術、產品和服務的開發商、製造商和銷售商，這些技術、產品和服務能夠推動生命科學應用的根本進步，包括研究、藥物和療法發現、生物生產以及藥物和療法開發的臨床前測試。我們的客戶包括著名的學術機構和政府實驗室，以及世界領先的製藥、生物技術和合同研究組織。我們在北美、歐洲和中國開展業務，通過直接和分銷渠道向世界各地的客戶進行銷售。欲了解更多信息，請訪問我們的網站

Investor Inquiries:

投資者查詢：

Harvard Bioscience, Inc.
Investor Relations
investors@harvardbioscience.com
(508) 893-3120

哈佛生物科學公司
投資者關係
investors@harvardbioscience.com
(508) 893-3120


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論